<DOC>
	<DOCNO>NCT02965404</DOCNO>
	<brief_summary>The purpose study evaluate safety live attenuate varicella vaccine healthy adult , adolescent , child .</brief_summary>
	<brief_title>A Safety Study Live Attenuated Varicella Vaccines Healthy Adults , Adolescents Children</brief_title>
	<detailed_description>This study randomize , blind , single-center , control phase I clinical trial . The purpose study evaluate safety live attenuate varicella vaccine manufacture Sinovac ( Dalian ) Vaccine Technology Co. , Ltd . The positive control commercialize live attenuated varicella vaccine manufacture Shanghai Institute Biological Products Co. , Ltd. ( SIBP ) , negative control diluent lyophilize vaccine manufacture Sinovac ( Dalian ) Vaccine Technology Co. , Ltd. All participant healthy , randomly assign experimental group , positive control group , negative control group ratio 1:1:1 .</detailed_description>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy volunteer 1 49 year old ; Proven legal identity ; Guardian ( ) volunteer and/or volunteer capable understanding write consent form , form sign infant include study ; Prior vaccination varicella vaccine history varicella zoster virus ( VZV ) infection ; Axillaty temperature &gt; 37.0 Â°C ; Breast feeding , pregnant , expect conceive period trial ; History allergy vaccine vaccine ingredient , serious adverse reaction ( ) vaccination , urticaria , difficulty breathing , angioneurotic edema , abdominal pain , etc ; History epilepsy , seizures convulsion , family history mental illness ; Autoimmune disease immunodeficiency ; Severe malnutrition , congenital malformation , developmental disorder , serious chronic disease ; Acute disease acute stage chronic disease within 7 day prior study entry ; Receipt follow product : 1 . Any subunit vaccine inactivate vaccine within 7 day prior study entry ; 2 . Any live attenuate vaccine within 1 month prior study entry ; 3 . Any blood product , immunosuppressant , hormone , investigational medicine ( ) within 30 day prior study entry ; Any significant abnormity heart , lung , skin , pharynx ; Any preimmune test result follow indexes laboratory test show clinically significant abnormity : 1 . Blood routine examination : hemoglobin ( Hb ) , white blood cell ( WBC ) count ; 2 . Blood biochemistry detection : alanine transferase ( ALT ) , total bilirubin , blood urea nitrogen ( BUN ) , creatinine ; 3 . Urine routine test : urine protein , urine glucose , urine erythrocyte Any factor suggest volunteer unsuitable study base opinion investigator ;</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>live attenuate varicella vaccine</keyword>
	<keyword>safety</keyword>
	<keyword>adult</keyword>
	<keyword>adolescent</keyword>
	<keyword>child</keyword>
</DOC>